摘要
Abstract
Objective Study of edaravone in cerebral infarction patients for nerve function improvement and clinical effect. Methods Selected in our hospital from 2008 September to 2012 September were a total of 105 cases of patients with cerebral infarction. Were randomly divided into two groups, the patients in the control group received routine treatment, the patients in the observation group received conventional therapy plus edaravone in the treatment of foundation. Results The control group before treatment in the patients with ESS neural function score was (25.3 ± 5.2), (6.9 ± 1.5) after treatment; observation group before treatment in the patients with ESS neural function score (25.1 ± 3.1), (14.2 ± 5) after treatment.Two groups of patients before and after the treatment of neurological function score have improved, but the patients in the observation group after treatment in the ESS score was lower than that in the control group of patients, there are significant differences between the two groups (P<0.01).In addition, two groups of serum hs-CRP, phosphate (PA) and lysophosphatidic acid (LPA) were decreased, but the patients in the observation group decreased significantly higher than that of the control group, there was significant difference between two groups (P<0.01). Conclusion Edaravone can effectively improve the neurological status of patients with cerebral infarction and can effectively reduce the levels of serum hs-CRP, PA and LPA, and it is conducive to the prognosis.关键词
依达拉奉/脑梗死/神经功能Key words
Edaravone/Cerebral infarction/Nerve function分类
医药卫生
